Balyasny Asset Management
VRNA

Balyasny Asset Management’s Verona Pharma VRNA Stock Holding History

Balyasny Asset Management’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$56.1M Buy
593,649
+132,420
2025
Q1 		$29.3M Buy
461,229
+277,332
2024
Q4 		$8.54M Buy
+183,897
2023
Q4 		– Sell
-10,024
2023
Q3 		$163K Buy
+10,024